NZX
15/05/2015 08:30
GENERAL
NOT PRICE SENSITIVE
REL: 0830 HRS NZX Limited
GENERAL: NZX: NZX congratulates the INFINZ Industry Awards 2015 winners
NZX wishes to congratulate the category winners of last night's INFINZ
awards, announced at the awards dinner in Auckland.
o Fisher & Paykel Healthcare - Market Leaders Best Corporate Communicator
o Abano Healthcare Group - Emerging Leaders Best Corporate Communicator
(sponsored by NZX)
o BNZ, Community Finance for low income earning individuals or families -
Institutional Banking Innovation
o Central Plains Water Enhancement Scheme, $150m Facilities to fund Stage 1 -
Debt Deal of the Year
o ASB Notes, NZ $400 million subordinated, unsecured debt securities - NZ
Debt Market Issue of the Year
o AMP Capital Investors - Fund Manager of the Year, Bonds
o Vista Group IPO - Equity Issue of the Year
o Devon Funds Management - Fund Manager of the Year, Equities
o Takeover of Synlait Farms by Synlait Farms Holdings - M&A Transaction of
the Year
o First NZ Capital Securities - Sharebroking Firm of the Year
o Stephen Ridgewell, Craigs Investment Partners - Research Analyst of the
Year
o Auckland International Airport - Excellence in Treasury
o Mike Daniell, CEO of Fisher & Paykel Healthcare - Leadership Award
For further information please contact:
Kate McLaughlin
Corporate Communications
T: 09 309 3654
M: 027 533 4529
E: [email protected]
About NZX Limited
NZX builds and operates capital, risk and commodity markets and the
infrastructure required to support them. We provide high quality information,
data and tools to support business decision making. We aim to make a
meaningful difference to wealth creation for our shareholders and the
individuals, businesses and economies in which we operate. To learn more
about NZX, please visit: www.nzxgroup.com
End CA:00264328 For:NZX Type:GENERAL Time:2015-05-15 08:30:12
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
